IBA is the world leader and market pioneer of proton therapy
Dallas, Texas (PRWEB) February 06, 2014
Proton therapy or proton beam therapy is a highly precise method of radiotherapy. The treatment is suitable for all patients regardless of age and as proton-therapy technology is continually advancing, features such as rotational gantries, higher energies and larger fields have expanded the treatment's application to potentially any site in the body. IBA is the world leader and market pioneer of proton therapy.
Geographical Coverage: Global, North America, Europe & Asia
Company Profiles: IBA Proton Therapy Inc., hi-tech, Varian Medical System & Mitsubishi Energy and Electrical Corporation
Buy a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=311709.
One of the chief arguments against the procedure of proton therapy is its massive cost as it is hugely expensive to set up and deliver a proton beam therapy center. Further, new technology such as pencil beam scanning is coming up which has the ability to treat the most complex of tumors, while leaving healthy tissue and critical structures untouched. This technology is used with proton therapy and many new proton centers are adopting this technology.
Globally the penetration of proton therapy centers is highest in North America, mainly in the US, followed by Europe and Asia. The US retains the highest number of proton therapy centers and many are in the development phase or under construction. Proton therapy technology has also made inroads in different countries as various governments are showing interest in this advanced technology. Proton therapy is still developing in Europe, mainly because of low awareness of this therapy and also because it is comparatively expensive. But as the therapy is getting acceptability because of its effectiveness, and this technology holds immense potential as evident in the growing number of proton centers across the world.
Finally the report analyzes the potential opportunities and significant trends in the global proton therapy market. The report also provides detailed analysis of the global proton therapy market, with data of regional markets such as North America, Europe and Asia. The report also profiles and analyzes the business strategies of the leading companies operating in the segment.
Major Points from Table of Contents (http://www.marketreportsonline.com/311709-toc.html) are listed below:
1 Executive Summary
3 Market Size of Proton Therapy Industry: Analysis and Forecast
4 North American Proton Therapy Market
5 European Proton Therapy Market
6 Asian Proton Therapy Market
7 Market Dynamics
8 Competitive Landscape
9 Company Profile
List of Tables
List of Figures
The Complete report “Global Proton Therapy Market: Trends & Opportunities (2013-2018)” available at http://www.marketreportsonline.com/311709.html.
Europe Orphan Drug Market Outlook 2018: http://www.marketreportsonline.com/311703.html.
US Orphan Drug Market Outlook 2018: http://www.marketreportsonline.com/311704.html.
MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the pharmaceauticals market, MarketReportsOnline.com offers research studies on agriculture, energy and power, chemicals, retail, environment, food and beverages, agriculture, consumer goods, healthcare, advanced materials, medical devices and much more.